Ipca Labs

{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,570.00",
    "chg": 39.2,
    "chgp": "2.56%",
    "dir": 1,
    "prev_price": "1,530.80",
    "mcapval": "39,629.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE571A01038",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "6.82 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ipca Laboratories Ltd Dips 0.89%: 3 Key Factors Behind the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-dips-089-3-key-factors-behind-the-weeks-mixed-momentum-3905305",
        "imagepath": "",
        "date": "2026-03-21 15:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Stock opens at Rs.1,555.20, dips 0.36%</p>\n                    <p><strong>17 Mar:</strong> New 52-week high at Rs.1,624; technical momentum shifts mildly bullish</p>\n                    <p><strong>18 Mar:</strong> Downgrade to Hold rating amid valuation and technical concerns</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.1,546.95, down 0.89% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,560.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..."
      },
      {
        "title": "Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-downgraded-to-hold-amid-valuation-and-technical-concerns-3898089",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3898089.png",
        "date": "2026-03-18 08:08:55",
        "description": "Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold by MarketsMOJO as of 17 March 2026. This revision reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong long-term returns and solid financials, evolving market dynamics and valuation pressures have prompted a more cautious stance."
      },
      {
        "title": "Ipca Laboratories Ltd Hits New 52-Week High at Rs.1624",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs1624-3896579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_priceRelatedfactors_3896579.png",
        "date": "2026-03-17 11:24:29",
        "description": "Ipca Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1624 today, marking a notable surge in its stock price and reflecting strong momentum within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3895715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_technicaldot_3895715.png",
        "date": "2026-03-17 08:03:20",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a slight dip in the daily price, the stock’s longer-term trend remains constructive, supported by a recent upgrade in its Mojo Grade from Hold to Buy, signalling renewed investor confidence."
      },
      {
        "title": "Ipca Laboratories Ltd Falls 2.67%: 2 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-falls-267-2-key-factors-driving-the-weekly-decline-3891527",
        "imagepath": "",
        "date": "2026-03-14 16:08:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 2:</strong> Significant gap down opening at Rs.1,403.70 amid market concerns</p>\n                    <p><strong>Mar 4:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>Mar 5:</strong> Price recovery with a 1.61% gain to Rs.1,499.85</p>\n                    <p><strong>Mar 6:</strong> Week closes at Rs.1,490.55, down 0.62% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,531.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..."
      },
      {
        "title": "Ipca Laboratories Gains 4.71%: 3 Key Factors Driving the Week’s Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-471-3-key-factors-driving-the-weeks-outperformance-3891017",
        "imagepath": "",
        "date": "2026-03-14 12:06:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 9:</strong> Stock opens at ₹1,506.45 despite Sensex decline</p>\n                    <p><strong>Mar 11:</strong> Valuation shifts signal renewed price attractiveness</p>\n                    <p><strong>Mar 12:</strong> Technical momentum upgrade to bullish</p>\n                    <p><strong>Mar 13:</strong> MarketsMOJO upgrades rating to Buy on strong fundamentals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,490.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,560.80</di..."
      },
      {
        "title": "MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-upgrades-ipca-laboratories-ltd-to-buy-on-strong-technical-and-financial-performance-3888184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3888184.png",
        "date": "2026-03-13 08:10:04",
        "description": "Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, solid financial performance, and a robust quality profile despite a shift to a more expensive valuation. The mid-cap pharmaceutical company’s recent market performance and operational metrics have prompted analysts to revise their outlook positively as of 12 March 2026."
      },
      {
        "title": "Ipca Laboratories Ltd Shows Strong Technical Momentum Amid Market Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-shows-strong-technical-momentum-amid-market-outperformance-3888112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_technicaldot_3888112.png",
        "date": "2026-03-13 08:02:14",
        "description": "Ipca Laboratories Ltd has demonstrated a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. This development, coupled with strong price performance relative to the Sensex, underscores renewed investor confidence in the mid-cap pharmaceutical and biotechnology company."
      },
      {
        "title": "Ipca Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3884296",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_valuationdot_3884296.png",
        "date": "2026-03-11 08:01:04",
        "description": "Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV) adjusting in line with peer averages and historical trends."
      }
    ],
    "total": 929,
    "sid": "950228",
    "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "details": "IPCA Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "IPCA Laboratories Limited has informed the Exchange regarding 'Update on US FDA'.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Updates",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "IPCA Laboratories Limited has informed the Exchange regarding ' a Conference Call to discuss the Company's Q2 FY20 earnings and business update will be held on Friday, 8th November, 2019 at 11.00 hrs IST'.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Updates",
      "datetime": "04-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ipca Laboratories Ltd Dips 0.89%: 3 Key Factors Behind the Week’s Mixed Momentum

2026-03-21 15:00:06

Key Events This Week

16 Mar: Stock opens at Rs.1,555.20, dips 0.36%

17 Mar: New 52-week high at Rs.1,624; technical momentum shifts mildly bullish

18 Mar: Downgrade to Hold rating amid valuation and technical concerns

20 Mar: Week closes at Rs.1,546.95, down 0.89% for the week

Week Open

Rs.1,560.80

Week Close

Read full news article

Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns

2026-03-18 08:08:55

Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold by MarketsMOJO as of 17 March 2026. This revision reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong long-term returns and solid financials, evolving market dynamics and valuation pressures have prompted a more cautious stance.

Read full news article

Ipca Laboratories Ltd Hits New 52-Week High at Rs.1624

2026-03-17 11:24:29

Ipca Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1624 today, marking a notable surge in its stock price and reflecting strong momentum within the Pharmaceuticals & Biotechnology sector.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-03-17 08:03:20

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a slight dip in the daily price, the stock’s longer-term trend remains constructive, supported by a recent upgrade in its Mojo Grade from Hold to Buy, signalling renewed investor confidence.

Read full news article

Ipca Laboratories Ltd Falls 2.67%: 2 Key Factors Driving the Weekly Decline

2026-03-14 16:08:51

Key Events This Week

Mar 2: Significant gap down opening at Rs.1,403.70 amid market concerns

Mar 4: Technical momentum shifts amid mixed market signals

Mar 5: Price recovery with a 1.61% gain to Rs.1,499.85

Mar 6: Week closes at Rs.1,490.55, down 0.62% on the day

Week Open

Rs.1,531.45

Week Close

...

Read full news article

Ipca Laboratories Gains 4.71%: 3 Key Factors Driving the Week’s Outperformance

2026-03-14 12:06:01

Key Events This Week

Mar 9: Stock opens at ₹1,506.45 despite Sensex decline

Mar 11: Valuation shifts signal renewed price attractiveness

Mar 12: Technical momentum upgrade to bullish

Mar 13: MarketsMOJO upgrades rating to Buy on strong fundamentals

Week Open

Rs.1,490.55

Week Close

Rs.1,560.80Read full news article

MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Performance

2026-03-13 08:10:04

Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, solid financial performance, and a robust quality profile despite a shift to a more expensive valuation. The mid-cap pharmaceutical company’s recent market performance and operational metrics have prompted analysts to revise their outlook positively as of 12 March 2026.

Read full news article

Ipca Laboratories Ltd Shows Strong Technical Momentum Amid Market Outperformance

2026-03-13 08:02:14

Ipca Laboratories Ltd has demonstrated a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. This development, coupled with strong price performance relative to the Sensex, underscores renewed investor confidence in the mid-cap pharmaceutical and biotechnology company.

Read full news article

Ipca Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-11 08:01:04

Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV) adjusting in line with peer averages and historical trends.

Read full news article

View All News